Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral nicotinamide to reduce serum phosphorus in hemodialysis patients
IRCT138809172817N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nicotinamide in end-stage kidney disease (ESKD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2009; status: completed.
02
Drugs
nicotinamide
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT138809172817N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138809172817N1.